Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description No. 10.1 Transition and Release Agreement, by and between the Company and Ronald McClurg, dated April 28, 2026 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 104 Cover Page Interactive Data File (embedded with Inline SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEUROONE MEDICAL TECHNOLOGIES CORPORATION Dated: April 30, 2026 By: /s/ David Rosa David Rosa Chief Executive Officer